ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 86 filers reported holding ADURO BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $341,000 | -61.6% | 221,154 | -0.7% | 0.00% | -100.0% |
Q1 2019 | $887,000 | +51.6% | 222,744 | +0.6% | 0.00% | 0.0% |
Q4 2018 | $585,000 | -64.1% | 221,453 | -0.1% | 0.00% | 0.0% |
Q3 2018 | $1,629,000 | +5.0% | 221,668 | +0.0% | 0.00% | 0.0% |
Q2 2018 | $1,551,000 | -25.5% | 221,568 | -1.0% | 0.00% | -50.0% |
Q1 2018 | $2,082,000 | +24.0% | 223,848 | +0.0% | 0.00% | 0.0% |
Q4 2017 | $1,679,000 | -29.5% | 223,808 | +0.1% | 0.00% | 0.0% |
Q3 2017 | $2,381,000 | -6.8% | 223,586 | -0.2% | 0.00% | -33.3% |
Q2 2017 | $2,555,000 | +6.8% | 224,101 | +0.7% | 0.00% | +50.0% |
Q1 2017 | $2,393,000 | -5.7% | 222,641 | +0.0% | 0.00% | -33.3% |
Q4 2016 | $2,538,000 | -8.3% | 222,630 | +0.0% | 0.00% | 0.0% |
Q3 2016 | $2,767,000 | +9.6% | 222,610 | -0.3% | 0.00% | 0.0% |
Q2 2016 | $2,524,000 | -11.7% | 223,180 | +0.0% | 0.00% | 0.0% |
Q1 2016 | $2,859,000 | -54.5% | 223,154 | +0.0% | 0.00% | -57.1% |
Q4 2015 | $6,279,000 | +45.2% | 223,121 | -0.0% | 0.01% | +40.0% |
Q3 2015 | $4,323,000 | -36.1% | 223,156 | +0.0% | 0.01% | -28.6% |
Q2 2015 | $6,766,000 | – | 223,084 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |